Literature DB >> 19793184

Analysis of flavonoid-based pharmacophores that inhibit aggrecanases (ADAMTS-4 and ADAMTS-5) and matrix metalloproteinases through the use of topologically constrained peptide substrates.

Mare Cudic1, Gayle D Burstein, Gregg B Fields, Janelle Lauer-Fields.   

Abstract

Polyphenolic natural products from green tea and red wine have been identified as metalloproteinase inhibitors. Members from the flavonoid and stilbene families found to possess metalloproteinase inhibitory activities include (-)-epigallocatechin gallate, (-)-epicatechin gallate and piceatannol, but their minimally active pharmacophores have not been evaluated. The present study has examined compounds that are structural components of or structurally related to (-)-epigallocatechin gallate, (-)-epicatechin gallate and piceatannol for inhibition of aggrecanases and four representative matrix metalloproteinases. Piceatannol and pyrogallol were found to inhibit all aggrecanases and matrix metalloproteinases studied, indicating a crucial reliance on multiple hydroxyl groups for (-)-epigallocatechin gallate, (-)-epicatechin gallate and piceatannol activity. Differences in K(i) values for pyrogallol as determined with two structurally distinct substrates indicated the likelihood that this compound binds in a non-competitive modality. Further analysis showed that pyrogallol acts as an exosite inhibitor, consistent with the action of (-)-epigallocatechin gallate. In contrast, piceatannol was shown to be a competitive binding inhibitor and showed no differences in apparent K(i) values as determined by distinct substrates, illustrating the benefits of using two structurally distinct substrates to assist the analysis of protease inhibitors. The compounds identified here could be utilized to develop novel metalloproteinase probes or as fragment components of more active inhibitors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19793184      PMCID: PMC2782546          DOI: 10.1111/j.1747-0285.2009.00885.x

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  43 in total

1.  Tumor invasion: molecular shears blunted by green tea.

Authors:  S Garbisa; S Biggin; N Cavallarin; L Sartor; R Benelli; A Albini
Journal:  Nat Med       Date:  1999-11       Impact factor: 53.440

Review 2.  Allosteric regulation of proteases.

Authors:  Patrick Hauske; Christian Ottmann; Michael Meltzer; Michael Ehrmann; Markus Kaiser
Journal:  Chembiochem       Date:  2008-12-15       Impact factor: 3.164

Review 3.  Natural occurring polyphenols as template for drug design. Focus on serine proteases.

Authors:  Massimiliano Cuccioloni; Matteo Mozzicafreddo; Laura Bonfili; Valentina Cecarini; Anna Maria Eleuteri; Mauro Angeletti
Journal:  Chem Biol Drug Des       Date:  2009-07       Impact factor: 2.817

4.  Matrix metalloproteinase inhibition by green tea catechins.

Authors:  M Demeule; M Brossard; M Pagé; D Gingras; R Béliveau
Journal:  Biochim Biophys Acta       Date:  2000-03-16

5.  Proteolytic activities of human ADAMTS-5: comparative studies with ADAMTS-4.

Authors:  Christi Gendron; Masahide Kashiwagi; Ngee Han Lim; Jan J Enghild; Ida B Thøgersen; Clare Hughes; Bruce Caterson; Hideaki Nagase
Journal:  J Biol Chem       Date:  2007-04-12       Impact factor: 5.157

6.  High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.

Authors:  Janelle L Lauer-Fields; Dmitriy Minond; Peter S Chase; Pierre E Baillargeon; S Adrian Saldanha; Roma Stawikowska; Peter Hodder; Gregg B Fields
Journal:  Bioorg Med Chem       Date:  2008-03-06       Impact factor: 3.641

7.  MMP-12 catalytic domain recognizes triple helical peptide models of collagen V with exosites and high activity.

Authors:  Rajagopalan Bhaskaran; Mark O Palmier; Janelle L Lauer-Fields; Gregg B Fields; Steven R Van Doren
Journal:  J Biol Chem       Date:  2008-06-06       Impact factor: 5.157

8.  Antitumor activities of synthetic and natural stilbenes through antiangiogenic action.

Authors:  Yoshiyuki Kimura; Maho Sumiyoshi; Kimiye Baba
Journal:  Cancer Sci       Date:  2008-10       Impact factor: 6.716

9.  Engineering functional antithrombin exosites in alpha1-proteinase inhibitor that specifically promote the inhibition of factor Xa and factor IXa.

Authors:  Gonzalo Izaguirre; Alireza R Rezaie; Steven T Olson
Journal:  J Biol Chem       Date:  2008-11-14       Impact factor: 5.157

10.  Differential inhibition of matrix metalloproteinases-2, -9, and -13 activities by selected anthraquinones.

Authors:  Claudia Wierzchacz; Enis Su; Jens Kolander; Rolf Gebhardt
Journal:  Planta Med       Date:  2009-01-16       Impact factor: 3.352

View more
  5 in total

Review 1.  Action mechanisms of complementary and alternative medicine therapies for rheumatoid arthritis.

Authors:  Imada Keisuke; Bao-lin Bian; Xiang-dong Li; Sato Takashi; Ito Akira
Journal:  Chin J Integr Med       Date:  2011-10       Impact factor: 1.978

2.  The nutraceutical flavonoid luteolin inhibits ADAMTS-4 and ADAMTS-5 aggrecanase activities.

Authors:  Angela Moncada-Pazos; Alvaro J Obaya; Cristina G Viloria; Carlos López-Otín; Santiago Cal
Journal:  J Mol Med (Berl)       Date:  2011-03-02       Impact factor: 4.599

Review 3.  Synthesis and biological applications of collagen-model triple-helical peptides.

Authors:  Gregg B Fields
Journal:  Org Biomol Chem       Date:  2010-01-20       Impact factor: 3.876

Review 4.  The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family.

Authors:  Richard Kelwick; Ines Desanlis; Grant N Wheeler; Dylan R Edwards
Journal:  Genome Biol       Date:  2015-05-30       Impact factor: 13.583

Review 5.  ADAMTS-18: a metalloproteinase with multiple functions.

Authors:  Jianlu Wei; Chuan-ju Liu; Zongdong Li
Journal:  Front Biosci (Landmark Ed)       Date:  2014-06-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.